These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 11191005

  • 1. Management of hypertension and dyslipidaemia in patients presenting with hyperuricaemia: case histories.
    Milionis HJ, Elisaf MS.
    Curr Med Res Opin; 2000; 16(3):164-70. PubMed ID: 11191005
    [Abstract] [Full Text] [Related]

  • 2. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia.
    Shahinfar S, Simpson RL, Carides AD, Thiyagarajan B, Nakagawa Y, Umans JG, Parks JH, Coe FL.
    Kidney Int; 1999 Nov; 56(5):1879-85. PubMed ID: 10571797
    [Abstract] [Full Text] [Related]

  • 3. Long-term remission from gout associated with fenofibrate therapy.
    Hepburn AL, Kaye SA, Feher MD.
    Clin Rheumatol; 2003 Feb; 22(1):73-6. PubMed ID: 12605325
    [Abstract] [Full Text] [Related]

  • 4. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J, ALLHAT Collaborative Research Group.
    Arch Intern Med; 2006 Nov 13; 166(20):2191-201. PubMed ID: 17101936
    [Abstract] [Full Text] [Related]

  • 5. AT1 blockers and uric acid metabolism: are there relevant differences?
    Puig JG, Torres R, Ruilope LM.
    J Hypertens Suppl; 2002 Jun 13; 20(5):S29-31. PubMed ID: 12184060
    [Abstract] [Full Text] [Related]

  • 6. Uric acid: role in cardiovascular disease and effects of losartan.
    Alderman M, Aiyer KJ.
    Curr Med Res Opin; 2004 Mar 13; 20(3):369-79. PubMed ID: 15025846
    [Abstract] [Full Text] [Related]

  • 7. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia.
    Milionis HJ, Kakafika AI, Tsouli SG, Athyros VG, Bairaktari ET, Seferiadis KI, Elisaf MS.
    Am Heart J; 2004 Oct 13; 148(4):635-40. PubMed ID: 15459594
    [Abstract] [Full Text] [Related]

  • 8. Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.
    Melenovsky V, Stulc T, Kozich V, Grauova B, Krijt J, Wichterle D, Haas T, Malik J, Hradec J, Ceska R.
    Am Heart J; 2003 Jul 13; 146(1):110. PubMed ID: 12851616
    [Abstract] [Full Text] [Related]

  • 9. [Uric acid--more deleterious than we thought?].
    Høieggen A, Os I, Kjeldsen SE.
    Tidsskr Nor Laegeforen; 2005 May 19; 125(10):1330-2. PubMed ID: 15909004
    [Abstract] [Full Text] [Related]

  • 10. The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide.
    Nikas S, Rizos E, Milionis H, Bairaktari E, Kalaitzidis R, Siamopoulos K, Elisaf M.
    J Renin Angiotensin Aldosterone Syst; 2000 Sep 19; 1(3):289-91. PubMed ID: 11881040
    [Abstract] [Full Text] [Related]

  • 11. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program.
    Can J Cardiol; 2004 Jan 19; 20(1):41-54. PubMed ID: 14968142
    [Abstract] [Full Text] [Related]

  • 12. Uric acid in hypertension and cardiovascular disease.
    Alderman M.
    Can J Cardiol; 1999 Nov 19; 15 Suppl F():20F-2F. PubMed ID: 10579748
    [Abstract] [Full Text] [Related]

  • 13. To study the efficacy of Losartan on urinary uric acid excretion in Thiazide induced hyperuricemic and hypertensive patients.
    Khan M, Khan RA, Islam F, Laghari J, Jamali SN.
    Pak J Pharm Sci; 2011 Oct 19; 24(4):583-7. PubMed ID: 21959825
    [Abstract] [Full Text] [Related]

  • 14. [Hypertension and hyperuricemia].
    Hirai A, Saitoh Y.
    Nihon Rinsho; 1996 Dec 19; 54(12):3283-8. PubMed ID: 8976106
    [Abstract] [Full Text] [Related]

  • 15. Uric acid levels and vascular disease.
    Daskalopoulou SS, Athyros VG, Elisaf M, Mikhailidis DP.
    Curr Med Res Opin; 2004 Jun 19; 20(6):951-4. PubMed ID: 15200754
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
    Naritomi H, Fujita T, Ito S, Ogihara T, Shimada K, Shimamoto K, Tanaka H, Yoshiike N.
    Hypertens Res; 2008 Feb 19; 31(2):295-304. PubMed ID: 18360050
    [Abstract] [Full Text] [Related]

  • 17. The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidaemic hypertensive patients.
    Coban E, Ozdogan M, Yazicioglu G, Sari R.
    Int J Clin Pract; 2005 Apr 19; 59(4):415-8. PubMed ID: 15853856
    [Abstract] [Full Text] [Related]

  • 18. [The pleiotropic effects of losartan--the importance of decreasing uric acid level].
    Csiky B, Markó L, Mohás M, Cseh J, Mikolás E, Szíjártó I, Wittmann I.
    Lege Artis Med; 2008 Oct 19; 18(10):663-6. PubMed ID: 19227608
    [Abstract] [Full Text] [Related]

  • 19. [The management of hyperuricemia associated with drug treatment of hypertension].
    Nakata T, Iimura O.
    Nihon Rinsho; 1992 May 19; 50 Suppl():116-9. PubMed ID: 1355121
    [No Abstract] [Full Text] [Related]

  • 20. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr 19; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.